Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission
Status:
Recruiting
Trial end date:
2031-12-31
Target enrollment:
Participant gender:
Summary
The study will explore the effects of early intensive antiretroviral therapy (ART) on
achieving HIV remission (HIV RNA below the limit of detection of the assay) among
HIV-infected infants.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
International Maternal Pediatric Adolescent AIDS Clinical Trials Group National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institute of Allergy and Infectious Diseases (NIAID)